These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17706611)

  • 1. Effects of (R,S)/(S,R)-4,5-bis(2-chloro-4-hydroxyphenyl)-2-imidazolines and (R,S)/(S,R)-2,3-bis(2-chloro-4-hydroxyphenyl)piperazines on estrogen receptor alpha level and transcriptional activity in MCF-7 cells.
    Laïos I; Cleeren A; Leclercq G; Nonclercq D; Laurent G; Schlenk M; Wellner A; Gust R
    Biochem Pharmacol; 2007 Oct; 74(7):1029-38. PubMed ID: 17706611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells.
    Bourgoin-Voillard S; Gallo D; Laïos I; Cleeren A; Bali LE; Jacquot Y; Nonclercq D; Laurent G; Tabet JC; Leclercq G
    Biochem Pharmacol; 2010 Mar; 79(5):746-57. PubMed ID: 19879249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations on the effects of basic side chains on the hormonal profile of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
    von Rauch M; Busch S; Gust R
    J Med Chem; 2005 Jan; 48(2):466-74. PubMed ID: 15658860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of C2-alkylation, N-alkylation, and N,N'-dialkylation on the stability and estrogen receptor interaction of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
    von Rauch M; Schlenk M; Gust R
    J Med Chem; 2004 Feb; 47(4):915-27. PubMed ID: 14761193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
    Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
    Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.
    Balan KV; Wang Y; Chen SW; Chen JC; Zheng LF; Yang L; Liu ZL; Pantazis P; Wyche JH; Han Z
    Biochem Pharmacol; 2006 Aug; 72(5):573-81. PubMed ID: 16822479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
    Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
    J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cobalt-alkyne complexes with imidazoline ligands as estrogenic carriers: synthesis and pharmacological investigations.
    Schlenk M; Ott I; Gust R
    J Med Chem; 2008 Nov; 51(22):7318-22. PubMed ID: 18942824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
    Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of GATA2-dependent transactivation of the TSHbeta gene by ligand-bound estrogen receptor alpha.
    Nagayama K; Sasaki S; Matsushita A; Ohba K; Iwaki H; Matsunaga H; Suzuki S; Misawa H; Ishizuka K; Oki Y; Noh JY; Nakamura H
    J Endocrinol; 2008 Oct; 199(1):113-25. PubMed ID: 18653622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of estrogen receptor-alpha in MCF-7 human breast cancer cells after proteasome inhibition.
    Balan KV; Wang Y; Chen SW; Pantazis P; Wyche JH; Han Z
    Biochem Pharmacol; 2006 Aug; 72(5):566-72. PubMed ID: 16806088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activity of estrogen receptors ERalpha and ERbeta in the EtC.1 cerebellar granule cell line.
    Gottfried-Blackmore A; Croft G; McEwen BS; Bulloch K
    Brain Res; 2007 Dec; 1186():41-7. PubMed ID: 18021758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERα dimerization: a key factor for the weak estrogenic activity of an ERα modulator unable to compete with estradiol in binding assays.
    Leclercq G; Laïos I; Elie-Caille C; Leiber D; Laurent G; Lesniewska E; Tanfin Z; Jacquot Y
    J Recept Signal Transduct Res; 2017 Apr; 37(2):149-166. PubMed ID: 27400858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity.
    Tharakan R; Lepont P; Singleton D; Kumar R; Khan S
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):70-8. PubMed ID: 18755239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth.
    DeNardo DG; Cuba VL; Kim H; Wu K; Lee AV; Brown PH
    Mol Cell Endocrinol; 2007 Oct; 277(1-2):13-25. PubMed ID: 17825481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
    Weitsman GE; Weebadda W; Ung K; Murphy LC
    Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.
    Saha P; Descôteaux C; Brasseur K; Fortin S; Leblanc V; Parent S; Asselin E; Bérubé G
    Eur J Med Chem; 2012 Feb; 48():385-90. PubMed ID: 22209414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
    Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
    J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol induces type 8 17beta-hydroxysteroid dehydrogenase expression: crosstalk between estrogen receptor alpha and C/EBPbeta.
    Rotinen M; Celay J; Alonso MM; Arrazola A; Encio I; Villar J
    J Endocrinol; 2009 Jan; 200(1):85-92. PubMed ID: 18852215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.